QA: ADC Therapeutics SA in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001771910_2025_ADC_Therapeutics_SA.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001771910, ADC Therapeutics SA

  xvar xval
0 AssetsCurrent 307,390,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 5,075,000
3 remainder_Assets 9,515,000
4 LiabilitiesCurrent 80,469,000
5 LiabilitiesNoncurrent 10,428,000
6 remainder_Liabilities 433,725,000
7 CostOfGoodsAndServicesSold 5,949,000
8 SellingGeneralAndAdministrativeExpense 41,894,000
9 ResearchAndDevelopmentExpense 109,633,000
10 remainder_Expenses 44,181,000
11 remainder_Revenues 70,837,000
12 remainder_NetIncome -27,026,000
13 remainder_ComprehensiveNetIncome -1,332,000
  yvar yval
0 Assets 321,980,000
1 Liabilities 524,622,000
2 Expenses 201,657,000
3 Revenues 70,837,000
4 StockholdersEquity -202,642,000
5 NetIncome -157,846,000
6 ComprehensiveNetIncome -158,512,000
7 BaseVar 573,727,000
8 EconomicCapitalRatiobeforeLimitedLiability -1.42
9 EconomicCapitalRatio 1.20

Edgar->Model Mapping

Feature Distribution

Change over Time